INSULATARD

This brand name is authorized in Austria, Cyprus, Germany, Estonia, Spain, France, Croatia, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom

Active ingredients

The drug INSULATARD contains one active pharmaceutical ingredient (API):

1 Insulin (human)
UNII 1Y17CTI5SR - INSULIN HUMAN

The blood glucose lowering effect of insulin is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver.

Read about Insulin (human)

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
INSULATARD Suspension for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A10AC01 Insulin (human) A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AC Insulins and analogues for injection, intermediate-acting
Discover more medicines within A10AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 00022958, 00022964, 00115039, 00115335, 00292161, 00579916, 00702251, 01825487, 01825493, 05039656, 05039722, 06430776, 06430807, 09012708, 10206091
Country: EE Ravimiamet Identifier(s): 1202757, 1202768, 1202779, 1202780, 1202791, 1202803, 1202814, 1202847, 1202858, 1202869, 1202870, 1202881, 1202892
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 02233003, 02233014
Country: FR Base de données publique des médicaments Identifier(s): 60423446, 62457123, 67248825, 69704932
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 32562, 32616, 32640
Country: IE Health Products Regulatory Authority Identifier(s): 61786, 71512, 71580
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 2576, 664
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1029202, 1029203, 1029204, 1029205, 1029206, 1029207, 1029208, 1029209, 1029210, 1029211, 1029212, 1029213, 1029214, 1029215, 1029216, 1029217, 1029218
Country: NL Z-Index G-Standaard Identifier(s): 14815974, 14815982, 14994658, 14996839
Country: NL Z-Index G-Standaard, PRK Identifier(s): 105716, 29998, 34851
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100030920, 100030943, 100030966, 100103174, 100311033
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W03713002, W03713003, W03714001, W03714002, W03714003, W13941001, W13941002, W13941003, W52580001, W52580002, W52580003, W52581002, W52581003, W52581004, W52582002, W52582003, W52582004
Country: SG Health Sciences Authority Identifier(s): 08654P, 08655P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 5993017, 5993026
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699676770489, 8699676950416

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.